Wu, R., Yuan, H., Wang, Y., Gou, X., Hou, W., Zhou, Z., . . . Yan, J. (2025). Norcantharidin inhibits TOP2A expression via H3K27me3 mediated epigenetic regulation to alleviate the progression of hepatocellular carcinoma. Frontiers in Pharmacology, 16, . https://doi.org/10.3389/fphar.2025.1541298
Chicago-referens (17:e uppl.)Wu, Ruibing, et al. "Norcantharidin Inhibits TOP2A Expression via H3K27me3 Mediated Epigenetic Regulation to Alleviate the Progression of Hepatocellular Carcinoma." Frontiers in Pharmacology 16 (2025). https://doi.org/10.3389/fphar.2025.1541298.
MLA-referens (9:e uppl.)Wu, Ruibing, et al. "Norcantharidin Inhibits TOP2A Expression via H3K27me3 Mediated Epigenetic Regulation to Alleviate the Progression of Hepatocellular Carcinoma." Frontiers in Pharmacology, vol. 16, 2025, https://doi.org/10.3389/fphar.2025.1541298.
